Biotech Acurx Pharmaceuticals, Inc. Announces Exercise of Warrants for $2.67 Million Gross Proceeds June 18, 2025
Biotech Clarivate Identifies Radioligand Therapy Innovators as Companies to Watch in the Future of Precision Oncology June 16, 2025
Biotech Innocan Pharma Highlights Breakthrough Narrative Review on Liposomal Synthetic CBD for Chronic Pain: A Novel Non-Opioid Analgesic Approach June 15, 2025
Biotech CureLab Veterinary’s ElenaVet™ Gene Therapy Delivers 90% Success in Pet-Dog Osteoarthritis Study June 14, 2025
Biotech Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels June 13, 2025
Biotech Ascend Completes GMP Certification for Quality Control Testing in Munich Facility June 11, 2025
Biotech SpliceBio Secures $135 Million Series B Financing to Advance Lead Program SB-007 in Stargardt Disease and Expand Pipeline of Genetic Medicines June 11, 2025
Biotech Everest Medicines Presents Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of Novel BTK Inhibitor EVER001 at the 62nd Congress of the European Renal Association June 9, 2025